TITLE-Characterization of a naturally occurring breast cancer subset enriched in EMT and stem cell characteristics Running title-Metaplastic breast cancer characterization
暂无分享,去创建一个
C. Fan | J. Fridlyand | K. Baggerly | G. Mills | J. Gray | G. Hortobagyi | Xiaping He | J. Palazzo | M. Carey | V. Weigman | V. Valero | Ju-Seog Lee | S. Krishnamurthy | Wenbin Liu | A. Lluch | B. Hennessy | A. González-Angulo | R. Agarwal | Wang | L. Nolden | C. Joy | M. Gilcrease | D. Stivers | C. Monteagudo | J. Nicholas | Șahin | Ayşegul | K. Stemke‐Hale
[1] A. Nobel,et al. Statistical Significance of Clustering for High-Dimension, Low–Sample Size Data , 2008 .
[2] Zhi Hu,et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. , 2008, Cancer research.
[3] T. Giordano,et al. Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast , 2008, Clinical Cancer Research.
[4] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[5] Susan G Hilsenbeck,et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.
[6] Roberto Piva,et al. The anaplastic lymphoma kinase in the pathogenesis of cancer , 2008, Nature Reviews Cancer.
[7] H. Juan,et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial–mesenchymal transition , 2007, Oncogene.
[8] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[9] Xuming He,et al. Non-parametric quantification of protein lysate arrays , 2007, Bioinform..
[10] L. Helman,et al. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism , 2007, Oncogene.
[11] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[12] S. Gabriel,et al. High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.
[13] E. S. Venkatraman,et al. A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..
[14] Gordon B. Mills,et al. The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis , 2007, Nature Cell Biology.
[15] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[16] Wendy Schackwitz,et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome , 2006, Nature Genetics.
[17] Zhiyuan Hu,et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.
[18] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[19] G. Mills,et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.
[20] S. Lakhani,et al. Metaplastic breast carcinomas are basal‐like tumours , 2006, Histopathology.
[21] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[22] Zhiyuan Hu,et al. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] G. Hortobagyi,et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] Ajay N. Jain,et al. Breast tumor copy number aberration phenotypes and genomic instability , 2006, BMC Cancer.
[25] C. Perou,et al. AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. , 2005, The Journal of clinical investigation.
[26] Zhiyuan Hu,et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay , 2006, Breast Cancer Research.
[27] G. Baffet,et al. Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells. , 2005, Journal of hepatology.
[28] Yiling Lu,et al. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.
[29] C. Chung,et al. Akt‐induced promotion of cell‐cycle progression at G2/M phase involves upregulation of NF‐Y binding activity in PC12 cells , 2005, Journal of cellular physiology.
[30] Greg Yothers,et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.
[31] Z. Li,et al. Gamma-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans , 2005, Journal of Medical Genetics.
[32] Gerolama Condorelli,et al. PED mediates AKT-dependent chemoresistance in human breast cancer cells. , 2005, Cancer research.
[33] J. Fridlyand,et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.
[34] Tina Hernandez-Boussard,et al. Determination of Stromal Signatures in Breast Carcinoma , 2005, PLoS biology.
[35] Hanina Hibshoosh,et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. , 2005, Cancer research.
[36] Kuo-Bin Li,et al. Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. , 2005, International journal of oncology.
[37] G. Mills,et al. Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells , 2004, Clinical Cancer Research.
[38] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[39] David C Christiani,et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines , 2004, Oncogene.
[40] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[41] G. Mills,et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells , 2003, Oncogene.
[42] Ajay N. Jain,et al. Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.
[43] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[46] H. Gutman,et al. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. , 1995, Journal of the American College of Surgeons.
[47] J. Avruch,et al. Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase. , 1993, Biochemistry.
[48] V. Eusebi,et al. Sarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. , 1993, Seminars in diagnostic pathology.
[49] H. Norris,et al. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. , 1989, Human pathology.